CD16A inhibitor

DRUG CLASS:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

CD19 positive + CD20 positive	Burkitt Lymphoma	CD19 positive + CD20 positive	Burkitt Lymphoma	rituximab + FT596 Sensitive: D – Preclinical rituximab + FT596 Sensitive : D	rituximab + FT596 Sensitive: D – Preclinical rituximab + FT596 Sensitive : D
CD19 positive	Acute Lymphocytic Leukemia	CD19 positive	Acute Lymphocytic Leukemia	FT596 Sensitive: D – Preclinical FT596 Sensitive : D	FT596 Sensitive: D – Preclinical FT596 Sensitive : D

Associations(2)